Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
Przepiorka D, Ippoliti C, Khouri I, Woo M, Mehra R, Le Bherz D, Giralt S, Gajewski J, Fischer H, Fritsche H, Deisseroth AB, Cleary K, Champlin R, Besien K, Andersson B, Maher R, Fitzsimmons W. Przepiorka D, et al. Among authors: maher r. Blood. 1996 Dec 1;88(11):4383-9. Blood. 1996. PMID: 8943876 Free article. Clinical Trial.
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR. Ratanatharathorn V, et al. Among authors: maher rm. Blood. 1998 Oct 1;92(7):2303-14. Blood. 1998. PMID: 9746768 Free article. Clinical Trial.
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR. Horowitz MM, et al. Among authors: maher r. Biol Blood Marrow Transplant. 1999;5(3):180-6. doi: 10.1053/bbmt.1999.v5.pm10392964. Biol Blood Marrow Transplant. 1999. PMID: 10392964 Free article. Clinical Trial.
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR. Devine SM, et al. Among authors: maher rm. Biol Blood Marrow Transplant. 1997 Apr;3(1):25-33. Biol Blood Marrow Transplant. 1997. PMID: 9209738 Clinical Trial.
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Wingard JR, Nash RA, Przepiorka D, Klein JL, Weisdorf DJ, Fay JW, Zhu J, Maher RM, Fitzsimmons WE, Ratanatharathorn V. Wingard JR, et al. Among authors: maher rm. Biol Blood Marrow Transplant. 1998;4(3):157-63. doi: 10.1053/bbmt.1998.v4.pm9923414. Biol Blood Marrow Transplant. 1998. PMID: 9923414 Free article. Clinical Trial.
Tacrolimus pharmacokinetics in BMT patients.
Boswell GW, Bekersky I, Fay J, Wingard J, Antin J, Weisdorf D, Maher R, Fitzsimmons W, Nash R. Boswell GW, et al. Among authors: maher r. Bone Marrow Transplant. 1998 Jan;21(1):23-8. doi: 10.1038/sj.bmt.1701054. Bone Marrow Transplant. 1998. PMID: 9486490 Clinical Trial.
224 results